Suchen
Kamada Ltd
KMDAZur Watchlist hinzufügen
7.500USD
-0.020-0.27%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
432.65MMarktkapitalisierung
21.41KGV TTM
mehr Informationen über Kamada Ltd Unternehmen
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Kamada Ltd Informationen
BörsenkürzelKMDA
Name des UnternehmensKamada Ltd
IPO-datumAug 01, 2005
CEOLondon (Amir)
Anzahl der mitarbeiter374
WertpapierartOrdinary Share
GeschäftsjahresendeAug 01
Addresse2 Holtzman St., Science Park
StadtREHOVOT
BörseNASDAQ OMX - NASDAQ BASIC
LandIsrael
Postleitzahl7670402
Telefon97289406472
Websitehttps://www.kamada.com/
BörsenkürzelKMDA
IPO-datumAug 01, 2005
CEOLondon (Amir)
Führungskräfte von Kamada Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
--
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
Ms. Pnina Strauss
Ms. Pnina Strauss
Vice President - Inhalation programs & IP
Vice President - Inhalation programs & IP
--
--
Mr. Tuvia Shoham
Mr. Tuvia Shoham
Independent Director
Independent Director
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
DR. Naveh Tov
DR. Naveh Tov
Vice President-Clinical Development and Medical
Director for Pulmonary Diseases
Vice President-Clinical Development and Medical
Director for Pulmonary Diseases
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
--
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Kamada Ltd?
Die fünf größten Anteilseigner von Kamada Ltd sind: Mr. Leon Yehuda Recanati
Wie viele Institutionen halten Anteile an Kamada Ltd (KMDA)?
Mit Stand vom 2026Q1 halten 98 Institutionen Anteile an Kamada Ltd, mit einem Gesamtmarktwert von etwa 28.17M, was 48.83% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -2157241.00 gestiegen.